Korean J Urol.  2013 Aug;54(8):527-530. 10.4111/kju.2013.54.8.527.

A Prospective Randomized Controlled Trial of the Efficacy of Tamsulosin After Extracorporeal Shock Wave Lithotripsy for a Single Proximal Ureteral Stone

• Park YH
• Lee HE
• Park JY
• Lee SB
• Kim HH

• KMID: 1840465
• DOI: http://doi.org/10.4111/kju.2013.54.8.527

Abstract

PURPOSE
The objective of this study was to evaluate the efficacy of tamsulosin on stone clearance after extracorporeal shock wave lithotripsy (ESWL) in patients with a single proximal ureteral stone.
MATERIALS AND METHODS
This prospective randomized controlled trial was performed on 88 patients with a single proximal ureteral stone. After consenting with a doctor, the patients were allocated to the treatment (tamsulosin 0.2 mg once a day) or control (no medication) group, and the efficacy of tamsulosin was evaluated. The primary outcome of this study was the stone-free rate, and the secondary outcomes were the period until clearance, pain intensity, analgesic requirement, and incidence of complications.
RESULTS
A stone-free state was reported in 37 patients (84.1%) in the treatment group and 29 (65.9%) in the control group (p=0.049). The mean expulsion period of the stone fragments was 10.0 days in the treatment group and 13.2 days in the control group (p=0.012). There were no statistically significant differences in aceclofenac requirement or pain score between the two groups. Only one patient in the treatment group experienced transient dizziness associated with medical expulsive therapy, and this adverse event disappeared spontaneously.
CONCLUSIONS
The results of this prospective randomized controlled trial of the efficacy of tamsulosin after ESWL for a single proximal ureteral stone suggest that tamsulosin helps in the earlier clearance of stone fragments and reduces the expulsion period of stone fragments after ESWL.

Keyword

Lithotripsy; Tamsulosin; Urolithiasis

MeSH Terms

Diclofenac
Dizziness
Humans
Incidence
Lithotripsy
Prospective Studies
Shock
Sulfonamides
Ureter
Urolithiasis
Diclofenac
Sulfonamides

Reference

1. Pearle MS, Lotan Y. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Urinary lithiasis: etiology, epidemiology, and pathogenesis. Campbell-Walsh urology. 2012. 10th ed. Philadelphia: Saunders Elsevier;1257–1410.

2. Pak CY. Kidney stones. Lancet. 1998. 351:1797–1801.

3. Anderson KR, Keetch DW, Albala DM, Chandhoke PS, McClennan BL, Clayman RV. Optimal therapy for the distal ureteral stone: extracorporeal shock wave lithotripsy versus ureteroscopy. J Urol. 1994. 152:62–65.

4. Gnanapragasam VJ, Ramsden PD, Murthy LS, Thomas DJ. Primary in situ extracorporeal shock wave lithotripsy in the management of ureteric calculi: results with a third-generation lithotripter. BJU Int. 1999. 84:770–774.

5. Aboumarzouk OM, Kata SG, Keeley FX, McClinton S, Nabi G. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2012. 5:CD006029.

6. Porfyris OT, Cutress ML, Tolley DA. The use of extra-corporeal shockwave lithotripsy for obstructing ureteric stones. Minerva Urol Nefrol. 2011. 63:175–182.

7. Seitz C, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U. Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol. 2009. 56:455–471.

8. Zehri AA, Ather MH, Abbas F, Biyabani SR. Preliminary study of efficacy of doxazosin as a medical expulsive therapy of distal ureteric stones in a randomized clinical trial. Urology. 2010. 75:1285–1288.

9. Pedro RN, Hinck B, Hendlin K, Feia K, Canales BK, Monga M. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol. 2008. 179:2244–2247.

10. Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005. 173:2010–2012.

11. Zhou SG, Lu JL, Hui JH. Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones. World J Urol. 2011. 29:767–771.

12. Sigala S, Dellabella M, Milanese G, Fornari S, Faccoli S, Palazzolo F, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn. 2005. 24:142–148.

13. Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S, Kohri K. Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol. 2007. 14:749–753.

14. Park HK, Choi EY, Jeong BC, Kim HH, Kim BK. Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. Urol Res. 2007. 35:325–329.

15. Zhu Y, Duijvesz D, Rovers MM, Lock TM. Alpha-blockers to assist stone clearance after extracorporeal shock wave lithotripsy: a meta-analysis. BJU Int. 2010. 106:256–261.

16. Zheng S, Liu LR, Yuan HC, Wei Q. Tamsulosin as adjunctive treatment after shockwave lithotripsy in patients with upper urinary tract stones: a systematic review and meta-analysis. Scand J Urol Nephrol. 2010. 44:425–432.

17. Han MC, Jeong WS, Shim BS. Additive expulsion effect of tamsulosin after shock wave lithotripsy for upper ureteral stones. Korean J Urol. 2006. 47:813–817.

18. Choi NY, Ahn SH, Han JH, Jang IH. The effect of tamsulosin and nifedipine on expulsion of ureteral stones after extracorporeal shock wave lithotripsy. Korean J Urol. 2008. 49:150–154.

19. Kang DI, Cho WY, Kim TH, Chung JM, Park J, Yoon JH, et al. Effect of tamsulosin 0.2 mg on the short-term treatment of urinary stones: multicenter, prospective, randomized study. Korean J Urol. 2009. 50:586–590.

20. Kim TH, Oh SY, Moon YT. The effect of tamsulosin on expulsion of ureteral stones after extracorporeal shock wave lithotripsy. Korean J Urol. 2008. 49:1100–1104.

21. Lee JK, Jeong CW, Jeong SJ, Hong SK, Byun SS, Lee SE. Impact of tamsulosin on ureter stone expulsion in Korean patients: a meta-analysis of randomized controlled studies. Korean J Urol. 2012. 53:699–704.